We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Psychedelics – News and Features

News

Vitalea Science Completes Dermal Distribution Microdose Study

Vitalea has completed a microdosing study assessing properties of a nutrient compound essential to prostate health and prevention of cellular oxidative damage.
News

Sensitive Pediatric Pharmacology Assays for HIV Drugs Developed by Vitalea Science

Vitalea recieves NIAID grant to develop and test assays that can be applied to children and neonates to quantify intracellular uptake of antiretroviral drugs.
News

Vitalea Science Announces Grant Award to Develop a Diagnostic Test Using MS Technologies

The Company receives SBIR grant to develop a medical diagnostic test to assess vitamin B12 malabsorption.
News

Accium BioSciences and CMIC Announce Strategic Alliance

Accium and CMIC Co. to offer Exploratory-IND (microdosing) and low-radiation PK/ADME clinical trials services to Japan pharmaceutical clients.
News

Xceleron Executes Microdose Agreement with Resverlogix

The study’s purpose is to administer sub-pharmacological dose levels of promising drug candidates in human volunteers.
News

Xcelleron Sign Agreement with Biofrontera

Companies collaborate to accelerate drug development using microdosing.
News

Xceleron Receives the Award for International Achievement at Yorkshire Bioscience Awards

Xceleron was recognized for its recent achievements overseas following the establishment of its subsidiary in the US.
News

Xceleron Leads EU Microdose AMS Partnership Programme

The programme aims to certify AMS technologies as appropriate methodologies for measurements required by microdosing studies.
News

Xceleron and Servier Sign Agreement to Accelerate Drug Development

The Agreement covers the provision by Xceleron of accelerator mass spectrometry services to assist Servier.
News

Xceleron Signs Three Year Preferred Supplier Agreement With GSK

Xceleron will provide support for GSK's bioanalytical AMS programme.
Advertisement